Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma

		Phase:		Phase 3

		Treatment ID#:		1714 RTOG 05-25

		Age Group:		Adult And Pediatric

		Min Karnofsky Score:		90: Able to perform normal activity; minor signs and symptoms of disease

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed

		Last Updated:		04/11/2008

		Tumor Types:		Glioblastoma Multiforme


		Comments:		The primary objective is to determine if increasing the "dose-density" of the adjuvant temozolomide component of the chemoradiation treatment enhances treatment efficacy as measured by overall survival.

		Treatment Type:		Chemotherapy Radiation

		Contact:		Steven Brem MD Program Leader, Neuro Oncology H. Lee Moffitt Cancer Center and Research Institute 12902 Magnolia Drive Suite 3136 MCC-NEURPROG Tampa, FL 33612 USA Phone: 813-979-3056 Fax: 813-903-7139 E-mail: entissa@moffitt.usf.edu Website: www.moffitt.usf.edu/Prevention_and_Treatment/clinical_programs/nonc/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By